Advanced Search
Contact | Corporate | Help

FCR and Bevacizumab in the Treatment of Relapsed CLL

Sponsors:
  • M.D. Anderson Cancer Center
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Chronic Lymphocytic Leukemia
Age Groups:
  • Child
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Fludarabine
  • Drug: Cyclophosphamide
  • Drug: Rituximab
  • Drug: Bevacizumab
Enrollment:
66

Additional information about NCT00448019.


SourceSolution © 2008-2012